Add an arm to two way BE study [Design Issues]

posted by AngusMcLean – USA, 2015-07-13 16:47 (3646 d 16:23 ago) – Posting: # 15075
Views: 7,848

(edited on 2015-07-14 23:59)

We have performed the usual comparison BE study with 2 sequences (AB, BA), 2 Periods, Latin Square Design, comparing two modified release formulations A and B in 16 subjects. Now after completing the cross-over treatments we are bringing back the same 16 subjects and we are going to administer Formulation B with different meals on the same date. {We realize that the best way of doing such a comparison would have been a 3 way cross over balanced study design in the first place}. The formulation comparison (B v A) for the randomized cross-over will of course be done as usual in Phoenix WinNonlin 6.4. We are going to combine the PK data parameters from Formulation B from Phase 1 and Phase 2 and compare them with the PK parameters from the added arm (formulation B) with different meals. I am thinking to treat the data as esentially a parallel group comparison. We believe that such a comparison, although inconsistent with regulatory requirements, will provide useful information at this stage of the programme.

Any thoughts are welcome,

Angus


Edit: title changed to lower case [Ohlbe]

Complete thread:

UA Flag
Activity
 Admin contact
23,427 posts in 4,929 threads, 1,681 registered users;
46 visitors (0 registered, 46 guests [including 10 identified bots]).
Forum time: 09:11 CEST (Europe/Vienna)

No matter what side of the argument you are on,
you always find people on your side
that you wish were on the other.    Thomas Berger

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5